NCT06679920Recruiting
Study With a Newly Optical Coherence Tomography Probe for Optimizing Bladder Cancer Diagnosis and Treatment
IDEAL Phase II Study of a Newly Designed Optical Coherence Tomography Probe During Transurethral Resection for Optimizing Bladder Cancer Diagnosis and Treatment
Source: ClinicalTrials.gov · Last updated 6 Dec 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The goal of this clinical trial is to see if a new designed optical coherence tomography catheter can be used in bladder cancer in patients undergoing a transurethral resection of a bladder tumour. The main question it aims to answer is: \- Is the optical coherence tomography catheter feasible in capturing images of bladder tumours and normal bladder wall during a transurethral resection of a bladder tumour? Participants will undergo measurements with a new optical coherence tomography device during the transurethral resection of their bladder tumour(s).
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- First submitted
- 5 Nov 2024
- Start date
- Dec 2024
- Primary completion date
- Mar 2025
- Lead sponsor
- Amsterdam UMC
- Diseases
- Bladder cancer
- NCT number
- NCT06679920
What you commit to
- Study type: Interventional
- Planned participants: 15
- From Dec 2024 to the primary completion date, Mar 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Pregnant or lactating women.
- The only tumour site is at the bladder neck.
- The tumour(s) is larger than 2 centimetres in diameter.
- \>5 tumours present.
- Solely a suspected flat lesion present.
Who the study is looking for
- Age \> 18 years.
- Have at least 1 suspected bladder tumour seen at cystoscopy.
- Have a bladder that is accessible for cystoscopy.
- Be in a physical condition to undergo a TURBT.
- Eligible patients must be fully informed about the study and written signed informed consent must be obtained prior to any study related investigation/intervention.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Amsterdam University Medical Center Coordinator of this site? Confirm its status | Amsterdam | Netherlands | Not yet recruiting |
Related publications
- Newly Designed Optical Coherence Tomography Catheter for Optimizing Bladder Cancer Diagnosis and Treatment: Protocol for a Feasibility Study.JMIR Res Protoc · 2025 · PMID 41329952
This page is information, not medical advice. Discuss any trial with your doctor.